Mechanisms of glucocorticoid-induced hyperglycemia include negative postreceptor effects on insulin action, resulting in insulin resistance, increased hepatic gluconeogenesis, and decreased tissue glucose uptake by skeletal muscle and adipose tissue by inhibition of glucose transporter type 4 expression (19-22). The gene discussed is INS; the disease is Insulin resistance.